Anti-EGFR drugs

A subset of colorectal cancers responds to anti-epidermal growth factor receptor ( anti-EGFR ) therapies, but develops resistance within months....


Results from a clinical trial conducted in Shanghai, China, have indicated that adding Cetuximab ( Erbitux ) to standard chemotherapy...


European Researchers have found that metastatic colorectal cancer patients with a mutation in the BRAF gene do not respond to...